A convenient and sensitive allergy test: IgE crosslinking-induced luciferase expression in cultured mast cells by Nakamura, R et al.
ORIGINAL ARTICLE EXPERIMENTAL ALLERGY AND IMMUNOLOGY
A convenient and sensitive allergy test: IgE crosslinking-
induced luciferase expression in cultured mast cells
R. Nakamura
1, Y. Uchida
1, M. Higuchi
1, R. Nakamura
1, I. Tsuge
2, A. Urisu
2 & R. Teshima
1
1Division of Novel Foods and Immunochemistry, National Institute of Health Science, Tokyo;
2Department of Pediatrics, Fujita Health
University School of Medicine, Toyoake, Aichi, Japan
To cite this article: Nakamura R, Uchida Y, Higuchi M, Nakamura R, Tsuge I, Urisu A, Teshima R. A convenient and sensitive allergy test: IgE crosslinking–
induced luciferase expression in cultured mast cells. Allergy 2010; 65: 1266–1273.
Food allergy occurs in 5–10% of infants and preschool chil-
dren and 1–2% of school children in Japan (1). Ideally, oral
food challenge (OFC) tests would be available for each
patient with food allergy to determine his/her responsive
allergens. However, it is often the case that OFC tests are
avoided because of the patient’s age, physical condition or
clinical history (2). The in vitro allergen-speciﬁc IgE test using
patients’ sera, like ImmunoCAP (CAP test), is widely used
for the initial screening purposes for responsive allergens.
The CAP test is a highly automated, convenient and very
sensitive method (sub ng/ml) for detecting serum IgE binding
to allergens (3). However, results of speciﬁc IgE binding to
allergens cannot always be translated into a clear diagnosis,
especially in the cases of food allergy (4, 5). Such clinically
irrelevant results in serum IgE tests can be partly explained
by cross-reactive carbohydrate determinants (CCDs) (5). The
CCD-speciﬁc IgE in patients’ sera can bind to the carbohy-
drate residue(s) in the allergen. However, if the carbohydrate
determinant has only one site per allergen, such binding
between the IgE and allergen would not induce mast cell acti-
vation because of failure to crosslink the high-afﬁnity IgE
receptor (FceRI) on the mast cells (6).
High-afﬁnity IgE receptor is a heterotetrameric receptor
composed of an a subunit, a b subunit, and a homodimer of
c subunit (7). Among these subunits, only the a subunit has
a binding ability to IgE, and expression of only the a subunit
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Abstract
Background: For the detection of allergen-speciﬁc IgE in sera, solid-phase IgE-bind-
ing assays like the CAP test are commonly used. Although such immunochemical
methods are very sensitive, they frequently produce false positives. Degranulation of
the human IgE receptor (FceRI)-transfected rat mast cell (RBL) lines seems to be a
possible indicator for human IgE, but spontaneous mediator release from these cells
in the presence of human sera is not negligible.
Methods: The nuclear factor of activated T-cells (NFAT)-responsive luciferase
reporter gene was stably transfected into human FceRI-expressing RBL-SX38 cells.
One established clone (RS-ATL8) was sensitized with 1 : 100 dilution of sera from
patients with egg white allergy and then stimulated with puriﬁed or a crude extract
of egg white allergen.
Results: Sensitization with 15 pg/ml IgE was sufﬁcient to detect IgE crosslinking–
induced luciferase expression (EXiLE) by anti-IgE stimulation. Allergen-speciﬁc
EXiLE was elicited by as little as 1 fg/ml of egg white protein without cytotoxicity.
There was a good correlation between results with EXiLE and oral food challenge
tests on patients with egg allergy (P = 0.001687, Fisher’s exact test). The measured
values of EXiLE and the CAP test also correlated well (R = 0.9127, Spearman’s
test).
Conclusion: The EXiLE test using RS-ATL8 cells is a promising in vitro IgE test to
evaluate the biological activity of the binding between IgE and allergens.
Abbreviations
EWP, Egg white proteins; EXiLE, IgE crosslinking–induced
luciferase expression; FCS, Fetal calf serum; FceRI, High-afﬁnity
IgE receptor; LDH, Lactate dehydrogenase; NFAT, Nuclear factor of
activated T-cell; OFC, oral food challenge; OVA, Ovalbumin;
RS-ATL8, RBL-SX38 cell stably transfected with NFAT-luciferase,
clone 8.
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far, there are no useful human mast cell lines that express
abundant FceRI and grow well (9–12). Therefore, human
FceRI-overexpressing rodent mast cell lines may be a useful
system for reﬂecting crosslinking of FceRI on mast cells trig-
gered by patients’ IgE and speciﬁc allergens. We and several
other groups have transfected a rat basophilic leukemia-
derived mast cell line, RBL-2H3, with the a subunit gene or
a complete set of a/b/c subunit genes of the human FceRI,
and analyzed the usefulness of the system (13–17). Among
these cell lines, a/b/c-transfected RBL cells were found to
have the potential to be sensitized with diluted patients’ sera
and degranulate after the addition of speciﬁc allergens. In
particular, RBL-SX38 cells, generated by Wiegand et al. (14),
were found to be the most effective (18). However, human
serum was cytotoxic at high concentrations (typically, more
than 1 : 10–1 : 20). To avoid cytotoxicity, investigators had
to sufﬁciently dilute serum (16), or remove the cytotoxic fac-
tors by adsorbing the sera to wild-type RBL-2H3 cells (15,
17, 18). These treatments could reduce the IgE concentration
in diluted sera, or increase experimental uncertainty through
increased manipulations. Moreover, the level of degranula-
tion was relatively low after such treatments, so artiﬁcial
‘accelerators’ of degranulation, such as an adenosine ana-
logue (15) or deuterium oxide (D2O; 12–14), were required to
measure meaningful responses. These compounds have been
reported to potentiate the degranulation of mast cells (19–
22), but the addition of high concentrations of D2O increased
spontaneous mediator release from these cells (18, 20, 21).
Crosslinking of FceRI on mast cells will also induce
marked gene expression of chemokines, cytokines, and other
proteins (23). A number of transcription factors participate
in such responses, and we previously demonstrated that
nuclear factor of activated T-cells (NFAT) appeared to play
one of the most important roles in FceRI crosslinking–
induced gene expression in RBL-2H3 cells (24).
Here, we show that the introduction of a NFAT-responsive
luciferase reporter gene into human FceRI-expressing RBL
cells is a convenient method for detecting IgE crosslinking–
induced mast cell activation with low-background and high
sensitivity. We designated the novel method as the ‘EXiLE’
test; IgE crosslinking–induced luciferase expression test.
Materials and methods
Cells
RBL-SX38 cells, expressing the human FceRI a/b/c-subunits,
were a kind gift from Dr Kinet at Beth Israel Deaconess
Medical Center (Boston, MA), and were maintained as previ-
ously reported (14). The NFAT-regulated luciferase reporter
gene plasmid containing hygromycin resistance gene were
purchased from Biomyx (San Diego, CA, USA). The plasmid
was linearized by Bgl I digestion, and was transferred into
RBL-SX38 cells using Lipofectamine 2000 (Invitrogen, Rock-
ville, MD, USA) following the manufacturer’s protocol. Stable
transfectants were selected using 600 lg/ml hygromycin. The
RS-ATL8 cell line, the highest luciferase responder subclone
after stimulation with 10 nM phorbol myristate acetate and
10 lM ionomycin, was established by limiting dilution and
was grown in minimum essential medium (MEM) (Invitrogen)
supplemented with 10% heat-inactivated fetal calf serum
(FCS; Nichirei Biosciences, Tokyo, Japan), penicillin/strepto-
mycin, GlutaMAX-I, 1.2 mg/ml geneticin, and 200 lg/ml
hygromycin (Invitrogen).
Human sera and allergens
Patients with suspected egg allergy referred to our hospital for
investigation were enrolled in the study. Most of the patients
had atopic dermatitis and asthma. Informed consent was
obtained from patients, their parents, or both to collect and
investigate serum samples further. The study was approved by
the institutional review board of National Institute of Health
Sciences and Ethics Committee of Fujita Health University
School of Medicine. All sera were collected before food chal-
lenge to measure total and allergen-speciﬁc IgE levels using
ImmunoCAP. Every patient was subjected to double-blind,
placebo-controlled food challenges with heated egg and was
judged positive if he or she was unable to eat the equivalent
of a whole boiled egg, as described previously (25). Pooled
sera from healthy donors were purchased from Cosmo Bio
(Tokyo, Japan). All sera were stored at )80 C until use. Puri-
ﬁed ovalbumin (OVA; grade V, >98%) was from Sigma
(St. Louis, MO, USA). To determine the allergen detection
limit, a 5 mg/ml egg white-extracted protein (EWP) solution
(Greer labs, Lenoir, NC, USA) was used. Egg white extract
(100 mg/ml of freeze-dried egg white powder in stock solu-
tion) prepared for the scratch diagnostic tests was purchased
from Torii Pharmaceutical (Tokyo, Japan) for the experi-
ments to determine the correlations between the allergy tests.
Luciferase assay
RS-ATL8 cells (5 · 10
4 cells/50 ll/well) were plated onto a
clear-bottom white 96-well plate (ViewPlate Perkin Elmer,
Waltham, MA, USA), and were incubated for several hours
at 37 C in a 5% CO2 incubator. Then, 5 ll of partly diluted
(11 : 100) or serially diluted sera in MEM containing 10%
FCS was added to the supernatant (ﬁnal dilution in the
former case, 1 : 100). After overnight incubation, the cells
were washed once with sterile PBS and then stimulated for
3 h at 37 C in a 5% CO2 incubator with allergens diluted in
MEM containing 10% FCS (50 ll/well). After stimulation,
50 ll of luciferase substrate solution containing cell lysis
reagent (ONE-Glo, Promega Corp., Tokyo, Japan) was
added to the cells, and chemiluminescence was measured
using an EnVision multilabel plate reader (Perkin Elmer).
Luciferase expression levels are represented as the fold
increase of light units compared with the background expres-
sion, after subtraction of a blank control (without cells).
b-Hexosaminidase assay
Stimulation-induced b-hexosaminidase release from RBL
cells was measured as described previously with some
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tized with serially diluted sera as described earlier. After
overnight incubation, the cells were washed twice with nor-
mal PIPES buffer (140 mM NaCl, 5 mM KCl, 0.6 mM
MgCl2, 1.0 mM CaCl2, 5.5 mM glucose, 0.1% BSA and
10 mM PIPES, pH 7.4). OVA (1 lg/ml) or goat anti-human
IgE antibody (Bethyl laboratories, Montgomery, TX, USA)
diluted in prewarmed PIPES buffer was added to the cells
(50 ll/well). After incubation for 30 min at 37 C, superna-
tants were collected, and residual cells were lysed with 0.2%
Triton X-100. Activity of b-Hexosaminidase in the medium
and within the cells was determined by a ﬂuorometric assay
using 4-methylumbelliferyl-N-acetyl-b-D-glucosaminide as a
substrate (0.1 mM in 100 mM citrate, pH4.5). The reaction
was stopped with 0.25 M glycine buffer after 30 min incuba-
tion at 37 C. The plate was read on a Fluoroskan Ascent
plate reader (Thermo Fisher Scientiﬁc, Waltham, MA, USA)
using 380 nm excitation and 440 nm emission ﬁlters. Degran-
ulation levels are represented as follows;
Rð%Þ¼ð Rsup   blankÞ=ðRsup   blank þ Rppt   blankÞ 100
where R is the degranulation level; Rsup is released enzyme
activity in the supernatant; Rppt is residual enzyme activity
within the cell; blank is the buffer control.
LDH release assay
Cytotoxicity of human sera on RS-ATL8 cells was measured
by a lactate dehydrogenase (LDH) release assay using the
Cytotoxicity Detection Kit
PLUS (Roche Diagnostics K.K.,
Japan) following the manufacturer’s protocol, and an EL340
(BioTek Instruments, Winooski, VT, USA).
Statistics
The cytotoxic effect of human serum was analyzed using a
1-way anova followed by Dunnett’s test compared with neg-
ative controls without human serum. Fisher’s exact test was
performed to analyze correlations between the OFC and
EXiLE or CAP tests. Spearman’s rank correlation test was
performed to compare the EXiLE and CAP test.
Results
RS-ATL8 cells
In the present study, we transfected an NFAT-responsive
luciferase reporter gene into human FceRI a/b/c-expressing
RBL-SX38 cells. We obtained 16 clones after hygromycin
resistance selection, and found that clone number 8 was the
highest responder to phorbol ester and ionomycin (data not
shown). This clone was designated as RS-ATL8; RBL-SX38
cell stably transfected with NFAT-Luciferase clone 8. The
cells were sensitized with serially diluted healthy donor’s
serum overnight, and then stimulated with 1 lg/ml goat anti-
human IgE antibody for 3 h. A dose-dependent increase in
EXiLE in the RS-ATL8 cells was observed (Fig. 1). The ori-
ginal serum contained 99 ng/ml (41 IU/ml) of IgE as revealed
by ELISA. If an expression level of two-fold background
(without serum) was set as a cut-off, EXiLE by anti-IgE
crosslinking exceeded the cut-off at 15 pg/ml of human IgE
(0.006 IU/ml). In our preliminary results, sensitization and
stimulation periods of 16 h (overnight) and 3 h, respectively,
resulted in the highest luciferase expression (data not shown).
Comparison of EXiLE to the b-hexosaminidase release
method
As previously reported, RBL-SX38 cells are capable of effec-
tively degranulating after sensitization using sera from
patients with peanut allergy and the addition of peanut aller-
gen (15, 19). However, human serum (1 : 10) was cytotoxic
to the cells, so it had to be cross-adsorbed against wild type
RBL-2H3 cells prior to the sensitization of RBL-SX38 cells
(15, 19). Moreover, when degranulation assays were per-
formed, it was usual for an ‘accelerator’ of degranulation,
like D2Oo r5 ¢-N-ethylcarboxamide, to be added to the med-
ium (15–18). Here, RBL-SX38 cells or RS-ATL8 cells were
similarly sensitized with serially diluted serum from egg
allergy patient’s (total IgE, 12 700 IU/ml; egg white speciﬁc
IgE, >100 UA/ml), and stimulated with 1 lg/ml of OVA and
anti-human IgE for 30 min in PIPES buffer or for 3 h in
10% FCS-containing MEM, respectively (Fig. 2). RBL-SX38
cells degranulated following stimulation with a speciﬁc
allergen even without a degranulation accelerator (Fig. 2A).
However, as serum concentration increased, spontaneous
release increased, particularly in cases of more than 0.1%
serum. The minimum and maximum spontaneous release was
14.6% and 34.9% of total enzyme, respectively. Meanwhile,
the background luciferase expression levels were gradually
decreased at >0.3% serum (Fig. 2B). EXiLE by OVA
exceeded 2.0 at 0.1% serum, and was >2.0 until 3% serum.
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Figure 1 Detection limit of IgE crosslinking–induced luciferase
expression. RS-ATL8 cells were sensitized with serial dilutions of
healthy donor’s serum in 10% Fetal calf serum-containing medium.
The total IgE concentration in the original serum was determined
by ELISA. After overnight incubation, the cells were stimulated
with (closed circles) or without (open circles) 1 lg/ml of anti-human
IgE for 3 h. Dashed line, two-fold level of the background (control
without serum) luciferase expression. §IgE = 15 pg/ml (0.006 IU/ml).
Data are means ± SEM (n = 4).
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in RS-ATL8 cells throughout the serum concentration range
tested (0.004–3%), whereas b-hexosaminidase release by anti-
IgE stimulation decreased nearly to the spontaneous release
levels at higher serum concentrations (Fig. 2A).
Appropriate serum dilution for EXiLE in RS-ATL8 cells
To determine the appropriate dilution factor for human sera,
anti-human IgE-induced luciferase expression and cell viabil-
ity after sensitization of RS-ATL8 cells with serially diluted
healthy donor’s serum were measured. LDH is a stable cyto-
solic enzyme and is released to the medium if the plasma
membrane is damaged (26). Anti-IgE stimulation elicited a
marked increase in the luciferase expression in RS-ATL8 cells
sensitized with 0.3% and 1% serum; however, at higher
serum concentrations (‡3–30%), the expression decreased
depending on the serum concentration (Fig. 3A). The
decrease was also seen in the nonstimulated controls. Such
decreases in luciferase expression inversely correlated to LDH
release (Fig. 3B), suggesting that human serum has a cyto-
toxic activity on the RS-ATL8 cells. In preliminary experi-
ments, this effect could be decreased by more than 50% by
heating the sera to 56 C for 30 min, suggesting heat-labile
factors (maybe complement) cause the cytotoxicity. However,
heat-inactivation was not to be performed in our experiments
because IgE is also heat-labile (27). Therefore, we concluded
that a 1 : 100-dilution was the most appropriate to determine
EXiLE without cytotoxicity.
Detection limit of allergen by means of EXiLE
We next tried to determine the detection limit of egg white
allergen using the patient’s serum. RS-ATL8 cells were sen-
sitized with 1 : 100-diluted patient serum or healthy donor
serum overnight, and were stimulated with EWP serially
diluted in MEM containing 10% FCS for 3 h. Figure 4
shows that EXiLE by EWP peaked at 1 ng/ml and
exceeded 2.0 at 1 fg/ml. The lot-to-lot reproducibility and
effect of cell passage number on the EXiLE test were deter-
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Figure 2 Comparison of degranulation and luciferase expression.
RBL-SX38 cells (A) and RS-ATL8 cells (B) were sensitized with
serial dilutions of egg white allergy patient’s serum (total IgE,
12 700 IU/ml; egg white speciﬁc IgE, >100 UA/ml) overnight. Cells
were stimulated with 1 lg/ml ovalbumin (shaded circles), 1 lg/ml
anti-human IgE (closed circles), or solvent alone (open circles). Sol-
vent does not include any degranulation accelerator such as D2O.
Degranulation after 30-min stimulation (A), and luciferase expres-
sion after 3-h stimulation (B) are shown. Dashed line in B, two-fold
level of background (control without serum) luciferase expression.
Data are means ± SEM (n = 4 in a, n = 3 in b).
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Figure 3 Appropriate serum dilution. RS-ATL8 cells were sensi-
tized with serial dilution of pooled healthy donor’s serum overnight.
Cells were stimulated with 1 lg/ml anti-human IgE (closed circles),
or solvent alone (open circles) for 3 h. (A) IgE crosslinking–induced
luciferase expression by anti-human IgE; (B) Cytotoxicity of human
serum on the RS-ATL8 cells revealed by lactate dehydrogenase
release. Dashed line in a, two-fold level of background (control
without serum) luciferase expression. Data are means ± SEM
(n = 4). *P < 0.05, **P < 0.01 (Dunnett’s test).
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fold increase in luciferase expression across six different time
points (Fig. S1). It was impossible to perform the same
experiment on b-hexosaminidase release from RBL-SX38
cells, because signiﬁcant spontaneous release (49%) was
induced by sensitization with the 1 : 100-diluted serum (data
not shown).
Comparison of EXiLE to OFC and CAP tests
Nineteen sera from suspected egg-allergy patients who had
been diagnosed by the OFC test (double-blind placebo-
controlled food challenge test) with heated egg and also by
the egg white–speciﬁc serum IgE test (CAP test) were sub-
jected to the EXiLE test for comparison. RS-ATL8 cells were
sensitized with 1 : 100-diluted patients’ sera, and stimulated
with 0, 1, 10, 100, and 1000 ng/ml of EWP, and EXiLE by
EWP was calculated by assuming the background expression
with no allergen was 1.0, and was judged to be positive if the
maximum EXiLE value (Max EXiLE) was ‡2.0. Table 1
summarizes the results; 12 of 19 patients were positive in the
OFC test, 18 of 19 were positive in the CAP test (class 2 as a
cut-off; speciﬁc IgE ‡ 0.70 UA/ml, a level indicated in the
manufacturer’s instruction), and 12 of 19 were positive in the
EXiLE test. Among 12 OFC positive patients’ sera, 11 and
12 were predicted to be positive by EXiLE and CAP tests,
respectively, while among 7 OFC negative patients’ sera, 6
and 1 were predicted to be negative by EXiLE and CAP
tests, respectively. As revealed by Fisher’s exact test, the
OFC and EXiLE tests correlated well (P = 0.001687),
whereas the OFC and CAP tests did not (P = 0.3684).
The EXiLE scores 1, 2, 3, and 4 correspond to the mini-
mum concentrations of responsive EWP; 1000, 100, 10, and
1 ng/ml, respectively, while 0 means a nonresponder. We
0
2
4
6
8
15 14 13 12 11 10 9 8 7 6
–Log10(EWP g/ml)
L
u
c
i
f
e
r
a
s
e
(
f
o
l
d
)
Figure 4 Detection limit of egg white allergen. RS-ATL8 cells were
sensitized with 1 : 100-diluted healthy donor’s serum (open circles)
or egg allergy patient serum (closed circles) overnight. Cells were
stimulated with the indicated concentrations of egg white proteins
(EWP) diluted in 10% Fetal calf serum-containing medium for 3 h.
Dashed line, two-fold level of background (0 g/ml EWP) luciferase
expression. Data are means ± SEM (n = 4).
Table 1 EXiLE in RS-ATL8 cells sensitized with egg-allergy patients’ sera
Patient
Age,
Sex
OFC*
test
totIgE
(IU/ml)
CAP
(UA/ml)
CAP
class
CAP*
test
EXiLE (fold) by EWP
(ng/ml)
Max
EXiLE (fold)
EXiLE
score
EXiLE*
test§
Anti-IgE
EXiLE (fold) 1 10 100 1000
#79 6, M + 1922 76.8 5 + 2.3 3.4 4.5 3.5 4.5 4 + 16.7
#77 13, M + 1273 68.6 5 + 4.1 8.8 9.5 7.5 9.5 4 + 17.9
#78 9,F + 844 48.3 4 + 4.8 8.3 8.4 8.6 8.6 4 + 17.6
#80 6,M + 381 35.1 4 + 1.5 3.0 3.9 5.0 5.0 3 + 12.0
#74 9,M + 2663 29.9 4 + 3.9 3.3 4.5 4.8 4.8 4 + 20.9
#90 14, F + 12323 25.6 4 + 1.5 2.5 2.8 2.8 2.8 3 + 16.7
#84 5,M + 331 13.2 3 + 1.5 1.7 2.3 1.9 2.3 2 + 7.84
#83 10, M + 772 8.98 3 + 1.3 1.7 2.5 3.2 3.2 2 + 17.7
#85 8,M + 619 5.57 3 + 1.6 2.5 3.4 3.1 3.4 3 + 24.2
#81 10, F + 795 4.54 3 + 1.5 2.2 1.8 2.7 2.7 3 + 19.5
#76 6,M + 509 3.91 3 + 1.4 1.7 2.0 2.2 2.2 2 + 23.0
#94 9,F + 653 2.99 2 + 0.8 1.3 1.3 1.5 1.5 0 ) 11.8
#73 9,F ) 7339 33.4 4 + 1.8 2.2 2.2 1.9 2.2 3 + 26.9
#67 13, M ) 22600 4.46 3 + 1.0 1.2 1.4 1.6 1.6 0 ) 14.2
#82 10, M ) 1470 3.45 2 + 1.2 1.2 1.5 1.4 1.5 0 ) 16.7
#95 5,F ) 578 2.03 2 + 1.1 1.2 1.3 1.5 1.5 0 ) 10.0
#75 6,M ) 1006 1.17 2 + 0.8 0.9 0.9 1.0 1.0 0 ) 25.0
#100 9,M ) 5356 0.89 2 + 0.9 1.3 1.5 1.4 1.5 0 ) 23.0
#99 13, M ) 475 <0.34 0 ) 1.1 1.1 1.3 1.5 1.5 0 ) 7.13
RS-ATL8 cells were sensitized with l : 100-diluted egg-allergy patients’ sera overnight, and stimulated with the indicated concentrations of
EWP or 1 lg/ml anti-IgE for 3 h. *Correlation between OFC and CAP tests was P=0.3684, and that between OFC and EXiLE tests was
P = 0.001687 (Fisher’s exact test). CAP test was considered positive if the class was ‡2 (i.e. ‡0.70 UA/ml) EXiLE score varies from 0 to 4.
Score 1, 2, 3, and 4 means its EXiLE exceeds 2.0 at EWP concentrations of 1000, 100, 10, and 1 ng/ml, respectively. Score 0 means
negative. §EXiLE test was judged to be positive if Max EXiLE was more than the cut-off level (2.0). Values greater than cut-off levels are
represented in Bold. EWP, Egg white proteins; EXiLE, IgE crosslinking–induced luciferase expression; OFC, oral food challenge.
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CAP and EXiLE tests by a Spearman’s rank test. Figure 5
illustrates that there are very good correlations between the
CAP and EXiLE scores (R = 0.9319, P < 0.001), and
between the CAP (speciﬁc IgE concentration) and Max
EXiLE values (R = 0.9127, P < 0.001).
Max EXiLE values and the ratio of speciﬁc/total IgE con-
centrations were also compared and found to correlate well,
but the Spearman’s correlation coefﬁcient was slightly lower
(R = 0.8561, P < 0.001) than that between CAP and Max
EXiLE. These results seemed to be consistent with a previous
study by Dibbern Jr. et al. (15), looking at the degranulation
of RBL-SX38 cells.
Discussion
In the present study, we have established a stable luciferase-
reporting humanized RBL clone, RS-ATL8, derived from the
previously described RBL-SX38 cells (14, 15). RBL-SX38 cells
released b-hexosaminidase on activation following sensitiza-
tion with serum from patients with egg allergy and stimula-
tion with EWP, without any degranulation accelerators
(Fig. 2A). However, there was signiﬁcant spontaneous release
from serum-sensitized but nonstimulated cells, which varied
from patient to patient (data not shown). In a previous
report, Ladics et al. described that humanized RBL cells,
including RBL-SX38 cells, were not conducive to using a
broad range of allergic subjects sera, because of difﬁculties in
generating consistent, robust responses (15). In our system,
human sera can be diluted 1 : 100, avoiding serum cytotoxic-
ity (Fig. 3B), and generate consistent responses without any
artiﬁcial accelerators with very high sensitivity (‡15 pg/ml
IgE). In appropriate conditions, our system can detect at least
1 fg/ml of allergen (Fig. 4). It is noteworthy that the medium
used here is supplemented with 10% FCS, which includes
incredible amounts of nonspeciﬁc proteins, ensuring the
robustness of the system. Indeed, antigen-speciﬁc luciferase
expression was observed either by puriﬁed allergen (Fig. 2B)
or by a mixture of egg white allergens (Fig. 4) with the same
patient’s serum. So far, nine food allergens (egg white, egg
yolk, milk, wheat, buckwheat, peanut, shrimp, crab, and
sesame) and three inhaled allergens (mite, cedar pollen, and
cat dander) were capable of inducing EXiLE in RS-ATL8
cells sensitized with speciﬁc patients’ sera. Some of the EXiLE
experiments undertaken for the screening of allergens are
shown in Fig. S2. As allergens are in the liquid phase in our
system, the degree-of-freedom for testing allergens appears to
be higher than in a solid phase system like CAP.
As shown in Table 1, comparative analysis of the EXiLE
test to the OFC test demonstrated that the predicted results
with the EXiLE test correlated well to the ﬁnal diagnosis
obtained with the OFC test (P = 0.001687, Fisher’s exact
test), whereas the results with the CAP test had no signiﬁcant
correlation to the OFC test (P = 0.3684). The low correla-
tion between the CAP and OFC tests here could be partially
explained by the high sensitivity of the CAP test. In CAP
tests, a class of 2 (‡0.70 UA/ml) is usually adopted for a cut-
off point following the manufacturer’s instructions. However,
Ando et al. (25) recently reported that the optimal cut-off
point of egg white–speciﬁc IgE was 2.82 and 7.38 UA/ml, for
the OFC tests with raw and heated egg white, respectively. In
addition, Komata et al. (28) also reported that the 95%
probability was achieved at 30.0 UA/ml for patients with egg
white allergy who were aged ‡2. Considering these aspects,
the class of 2 might be too strict to exclude false positives, at
least for the patients in the present study. If a CAP class of 3
(‡3.50 UA/ml) was set as a cut-off in Table 1, the correlation
of the results with the CAP test and OFC test would increase
to a signiﬁcant level (P = 0.009546). Therefore, the CAP test
is so sensitive that it seems to be suitable for the ﬁrst screen-
ing of allergen-speciﬁc IgE in the sera.
Both of the scores (Fig. 5A) and values (Fig. 5B) from the
EXiLE and CAP tests correlated well. These results strongly
suggest that an increase in the luciferase expression observed
in RS-ATL8 cells reﬂects crosslinking of the antigen-speciﬁc
IgE bound to FceRI on the mast cells. Therefore, these three
systems seemed to correlate well, but there were several spe-
ciﬁc differences in the results between them (Table 1). Com-
pared with the OFC results, the EXiLE test predicted one
false-negative (#94) and one false-positive (#73). Reasons for
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Figure 5 Correlation between CAP test and IgE crosslinking–
induced luciferase expression (EXiLE) test. Results in Table 1 are
depicted in graphic form. Correlation between CAP classes and
EXiLE scores (A), and that of allergen-speciﬁc IgE concentration
and Max EXiLE (B) are shown. Closed and open circles, subjects
from oral food challenge positive and negative, respectively. Verti-
cal and horizontal dashed lines, cut-off levels of the CAP and EXiLE
test, respectively. R-values of Spearman’s rank correlation test
were 0.9139 (P < 0.001) in A, and 0.9127 (P < 0.001) in B.
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because of the higher detection limit of the EXiLE system, as
serum #94 contained no more than 2.99 UA/ml speciﬁc IgE.
Another possibility is that other substances, like chemokines
and cytokines, can induce histamine release from human
basophils (29, 30). As RS-ATL8 cells only have human
FceRI, the cells would not be activated through IgE-indepen-
dent mechanisms like these. This might also be an explana-
tion for the false-positive case. If neutralizing IgG antibodies
(31) against EWP were present in vivo, it would not be
strange that oral challenge did not show marked symptoms
in the patient, whereas antibodies other than IgE in the
patient’s serum will be washed away from the medium before
the addition of speciﬁc antigen to RS-ATL8 cells in the pres-
ent study. A qualitative change in epitopes by heat and/or
digestion could be another possibility.
One noteworthy example is patient #67, whose serum con-
tained 4.46 UA/ml (class 3) of egg white–speciﬁc IgE, but can
eat eggs with no allergic symptoms. With this serum, EXiLE
levels were gradually increased to 1.6 depending on EWP
concentration, but did not exceed the 2.0 cut-off level
(Table 1). Considering the substantially high level of total
IgE in his serum (22 600 IU/ml), most of the speciﬁc IgE
seems to be biologically meaningless cross-reactive antibodies,
lacking the ability to activate mast cells and basophils (5, 32).
It is important to distinguish such patients from the CAP-
positive patient group because food avoidance is unnecessary
and would lower the quality of life for such patients (33).
The EXiLE test could be suitable for this purpose, screening
allergen-speciﬁc IgE in sera following immunochemical
in vitro tests like CAP.
This novel in vitro technique might be applicable to: (i)
second screening of allergen-speciﬁc IgE in the serum follow-
ing CAP tests, (ii) cross-reactivity tests between known aller-
gens and potential allergens (safety assessment of gene-
modiﬁed crops), (iii) standardization of allergen extracts for
clinical usage, (iv) screening of novel allergens and/or
epitopes, (v) detection of small amounts of allergens in foods,
(vi) epidemiological study of allergens using a serum bank,
and (vii) high-throughput screening for the seed compounds
of anti-allergic drugs.
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